A hybrid-system model of the coagulation cascade: simulation, sensitivity, and validation
Joseph G Makin1, Srini Narayanan
1Department of Electrical Engineering and Computer Science, University of California, Berkeley, USA , International Computer Science Institute, Berkeley, CA 94720, USA.
Journal of Bioinformatics and Computational Biology
|October 18, 2013
Summary
This study introduces a hybrid dynamical system model for human blood clotting, integrating continuous and discrete processes. This novel approach enhances accuracy in simulating clotting dynamics and predicting pathologies.
Area of Science:
- Biophysics
- Computational Biology
- Systems Biology
Background:
- Human blood clotting is a complex cascade involving continuous chemical reactions and discrete events.
- Previous models primarily used continuous dynamics, limiting their ability to capture the full clotting process.
Purpose of the Study:
- To develop a comprehensive model of blood clotting that integrates both continuous and discrete dynamical aspects.
- To utilize a hybrid dynamical system approach for enhanced simulation and prediction of clotting phenomena.
Main Methods:
- Modeled blood clotting as a hybrid dynamical system.
- Implemented the model using a hybrid Petri net, extending ordinary Petri nets for continuous flows and quantities.
- Focused on simulation fidelity, reproduction of pathologies, and fine-grained predictions.
Main Results:
- The hybrid Petri net model successfully captures both continuous and discrete aspects of blood clotting.
- Simulations demonstrated fidelity to clinical data regarding clotting factors and time.
- The model reproduced known clotting pathologies and offered potential for refined clinical understanding.
Conclusions:
- Hybrid dynamical systems offer a powerful framework for modeling complex biological processes like blood clotting.
- The developed hybrid Petri net model provides a more accurate and comprehensive representation of coagulation.
- This approach facilitates improved simulation, prediction, and understanding of blood clotting mechanisms and pathologies.
Related Concept Videos
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation
8.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.5K
Extrinsic and Intrinsic Pathways of Hemostasis
11.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.1K
Introduction to Hemostasis
14.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.5K


